Naftifine hydrochloride (naftifine), chemically known as (E)-N-Cinnamyl-N-methyl-1-napthalenemethylamine hydrochloride is an antifungal drug used to topically treat fungal infections such as tinea pedis (athletes foot), tinea cruris (jock itch), tinea corporis (ringworm), and others. It is a synthetic allylamine antifungal compound. Naftifine is only prescribed for topical application. This ointment has a complete anti-microbial mechanism of action comprising anti-fungal, anti-bacterial, and anti-inflammatory activity.

Market Analysis and Insights: Global Naftifine Hydrochloride Ointment Market
The global Naftifine Hydrochloride Ointment market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Naftifine Hydrochloride Ointment Scope and Market Size
The global Naftifine Hydrochloride Ointment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Naftifine Hydrochloride Ointment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Adults
Children

Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce

The Naftifine Hydrochloride Ointment market is analysed and market size information is provided by regions (countries). Segment by Application, the Naftifine Hydrochloride Ointment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Merz Dermatology
Parchem Fine and Specialty Chemicals
LGM Pharma
Sebela Pharmaceuticals
Erregierre
Simagchem Corporation
Taro Pharmaceutical Industrues
Renaissance Pharma
Shanghai Yisa Biotechnology
Shaanxi TOP Pharm Chemical